Jerome Grove, MD
Interventional Pain Medicine · Phoenix, AZNPI 1932153236
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (56.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 46 manufacturers reported payments, led by West Therapeutics Development, LLC at 47.5% of the total. Reporting peaked in 2019 at $14,394 and has fallen 95.1% since, to $708 in 2025.
Across 517 payments — averaging $41.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- West Therapeutics Development, LLC$10K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$3K
- AbbVie$1K
- Collegium Pharmaceutical, Inc.$795
- Medtronic$683
- Nevro Corp.$637
- plus $5K from 40 others
What the payments were for
- Speaking & faculty fees$12,00057%
- Travel & lodging$140%
- Food & beverage$9,16843%
- Education$540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lazanda$10,000
- RELISTOR$2,000
- INTELLIS ADAPTIVESTIM$280
- Morphabond ER$166
- Senza Spinal Cord Stimulation System$148
- Nalu Neurostimulation System$138
- UNID_PASS$136
- SUPERION$116
- Lucemyra/Lofexidine$110
How this compares
$21,236 in reported general payments places this provider in the 80th percentile of 64 interventional pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 18 | $17,560 |
| BotoxOnabotulinumtoxina | 11 | $13,109 |
| Xtampza ErOxycodone Myristate | 24 | $11,918 |
| Oxycodone Hcl | 267 | $5,739 |
| Fentanyl | 46 | $5,211 |
| Celecoxib | 41 | $5,170 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 140 | $3,591 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 118 | $3,520 |
| Morphine Sulfate ErMorphine Sulfate | 127 | $2,984 |
| Gabapentin | 139 | $1,895 |
| Hydromorphone Hcl | 92 | $1,631 |
| Naloxone Hcl | 21 | $1,407 |
| Pregabalin | 51 | $1,023 |
| Baclofen | 50 | $801 |
| Diclofenac Sodium | 73 | $770 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieBotox | $1,383 | $13,10911 claims |
| Collegium Pharmaceutical, Inc.Xtampza Er | $795 | $11,91824 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 64 interventional pain medicine providers in Arizona.
Other interventional pain medicine in Phoenix
- Steven SiwekPhoenix$57K
- Ramoun JonesPhoenix$51K
- Lisa StearnsPhoenix$48K
- Thomas MoshiriPhoenix$19K
- Abram BurgherPhoenix$15K
- Adam SiwekPhoenix$14K
- Todd TurleyPhoenix$13K
- Jarrett LeathemPhoenix$11K
- Ankit PatelPhoenix$8K
- Chhavi ManchandaPhoenix$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.